Related Experiment Video
Updated: Jun 19, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
A CONTRIBUTION TO THE CHEMOTHERAPY OF TUBERCULOSIS : FIRST EXPERIMENTAL REPORT
1Kitasato Institute for Infectious Diseases, Tokyo, Japan.
Abstract:
JUDGING FROM THE MACROSCOPIC AND MICROSCOPIC STUDY OF THE ANIMALS TREATED WITH THE LIQUID, ITS ACTION UPON THE TUBERCULAR LESIONS SEEMS TO BE ABOUT AS FOLLOWS: The effect of a single injection upon the lesions is either negative or inconspicuous. But after repeated injections of the preparation the congestion and leukocytic infiltration about the lesions are markedly decreased, the cheesy material resulting from degeneration of the lesions and other degeneration products are in process of absorption, and young connective tissue is being actively produced in the periphery. While these changes are taking place the number of the bacilli is also being reduced until finally they can no longer be detected on microscopic examination. Hence it appears that while the preparation may lack bactericidal action in vivo powerful enough to destroy all the bacilli at one injection, yet repeated infusions may nevertheless bring about the destruction of all the bacilli and the modification of the tubercular lesion into that of the suspended stage or even into the healed condition. Whether, therefore, the preparation brings about these results directly by killing the bacilli or indirectly by favoring the healing processes of the body, nevertheless it has power to inhibit the growth of or annihilate entirely the bacilli in vivo. The experiments reported leave no doubt that Liquid D is capable of bringing about the healing of experimental tubercular lesions; but thus far that most important problem in chemotherapeutics, namely, the extent of the cure produced, has not been solved. The experiments indicate that sterility of the tissues as far as microscopic examinations go has been secured; but microscopic examination is not after all an absolute test of sterility. In order to test this point, emulsions were made of the lungs, liver, spleen, and other organs of Treated Animals 134 and 135 (Table VII), and they were inoculated into the abdominal cavity of guinea pigs. Some of the animals receiving the emulsion developed tuberculosis, and therefore absolute sterility of the treated animals had not been obtained in these instances. The problem of the destination and distribution of the preparation in the body of the treated animal, as well as its action against the tubercle bacilli, lesions, and the tubercular organs of the infected guinea pigs, is now being studied further with results to be reported at some future time.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis
